Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.
Fernando J MartinezKlaus F RabeBrian J LipworthSamir AroraMartin JenkinsUbaldo J MartinColin ReisnerPublished in: International journal of chronic obstructive pulmonary disease (2020)
GFF MDI significantly improved lung function versus monocomponents and placebo MDI in GOLD category A patients with moderate-to-very severe COPD, with no unexpected safety findings.